Harbour Antibodies Overview

  • Founded
  • 2006
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 10
Employees
  • Latest Deal Type
  • M&A

Harbour Antibodies General Information

Description

Developer of transgenic mice platforms to aid in the discovery of human antibody-based therapies. The company develops human immunoglobulin gene transgenic mice which help in the generation of tetrameric antibodies comprising two heavy and two light immunoglobulin chains.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Parent Company
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Harbour Antibodies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 19-Dec-2016 00.000 Completed Generating Revenue
1. Later Stage VC (Series A) 24-Jul-2013 00.000 00.000 Completed Generating Revenue
To view Harbour Antibodies’s complete valuation and funding history, request access »

Harbour Antibodies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of transgenic mice platforms to aid in the discovery of human antibody-based therapies. The company develops h
Biotechnology
10 As of 2016
00.000
000000&0 00.000

00000000

t, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. U
0000000000000
Gaithersburg, MD
00 As of 0000
00000
0000 0000-00-00
00000000 00000

0000000

gna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea
0000000000000
Brisbane, CA
000 As of 0000
000.00
00000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Harbour Antibodies Competitors (27)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NexImmune Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
0000000 0000000000 Formerly VC-backed Brisbane, CA 000 000.00 00000000 000.00
0000000 0000000000 Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
00000000 Venture Capital-Backed San Carlos, CA 00 00000 00000000000 00000
00000000000 Formerly VC-backed Culver City, CA 000 00000 000000000000 00000
You’re viewing 5 of 27 competitors. Get the full list »

Harbour Antibodies Executive Team (3)

Name Title Board Seat Contact Info
Frank Grosveld Ph.D Co-Founder, Chief Scientific Officer and Board Member
Riet Van Zeijl Financial Controller
You’re viewing 2 of 3 executive team members. Get the full list »

Harbour Antibodies Board Members (4)

Name Representing Role Since
Kees Scholtes Self Board Member 000 0000
Robert Kamen Ph.D Self Board Member 000 0000
You’re viewing 2 of 4 board members. Get the full list »

Harbour Antibodies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Harbour Antibodies Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Atlas Venture Venture Capital Minority 000 0000 000000 0
Erasmus MC Biomedical Fund Venture Capital Minority 000 0000 000000 0
To view Harbour Antibodies’s complete investors history, request access »